The effect of Soldactona (canrenoate-potassium) on plasma testosterone and androstenedione and urinary 17-ketosteroids and 17-hydroxycorticosteroids.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000172:Acromegaly / Q000097:blood / Q000652:urine; D000328:Adult; D000368:Aged; D000731:Androstanes / Q000097:blood*; D002940:Circadian Rhythm; D005260:Female; D006801:Humans; D006914:Hydroxysteroids / Q000494:pharmacology; D006929:Hyperaldosteronism / Q000097:blood / Q000652:urine; D006973:Hypertension / Q000097:blood / Q000652:urine; D007664:Ketosteroids / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D011278:Pregnanes / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology; D013739:Testosterone / Q000097:blood* / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000731:Androstanes; D006914:Hydroxysteroids; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D011278:Pregnanes; D011422:Propionates; D013739:Testosterone